SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-007827
Filing Date
2019-03-14
Accepted
2019-03-14 16:16:17
Documents
44
Period of Report
2019-01-31

Document Format Files

Seq Description Document Type Size
1 Q3-19 10-Q kalv-10q_20190131.htm 10-Q 1278258
2 EX-10.1 kalv-ex101_209.htm EX-10.1 47764
3 EX-10.2 kalv-ex102_208.htm EX-10.2 6538
4 EX-31.1 kalv-ex311_6.htm EX-31.1 21430
5 EX-31.2 kalv-ex312_8.htm EX-31.2 18686
6 EX-32.1 kalv-ex321_7.htm EX-32.1 8620
  Complete submission text file 0001564590-19-007827.txt   3543318

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT kalv-20190131.xml EX-101.INS 563882
8 XBRL TAXONOMY EXTENSION SCHEMA kalv-20190131.xsd EX-101.SCH 28041
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kalv-20190131_cal.xml EX-101.CAL 43816
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kalv-20190131_def.xml EX-101.DEF 63087
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE kalv-20190131_lab.xml EX-101.LAB 215840
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kalv-20190131_pre.xml EX-101.PRE 151685
Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-36830 | Film No.: 19681274
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1